Fig. 4From: Identifying inflammatory bowel disease patients at risk of metabolic dysfunction-associated fatty liver disease: usefulness of non-invasive steatosis predictive scoresOriginal formula of Clinical Prediction Tool for NAFLD in Crohn’s Disease [15]. ALT alanine aminotransferase, AST aspartate aminotransferase, BMI body mass index, CD Crohn’s Disease, T2DM type 2 diabetes mellitusBack to article page